As a wholly owned subsidiary of ElectroSonics, our mission is to advance the development of medical diagnostic tools using proprietary radar technology. In line with this mission PneumoSonics Inc. is in the final stages of the commercialization of a handheld pneumothorax detector. In addition to the pneumothorax device, PneumoSonics Inc. is also in the development process of additional handheld, portable diagnostic devices.

PneumoSonics Inc. was formed in April 2008 after certain assets of BIOMEC Inc. were acquired by Greatbatch Ltd. of Buffalo NY. Two technologies being developed by BIOMEC Inc. before the acquisition were specifically excluded from the transaction, one of which is the Pneumothorax Detector "PneumoScan". PneumoSonics Inc. was formed to continue the development, clinical and commercialization activities for the retained technologies previously initiated by BIOMEC Inc.

BIOMEC Inc.'s mission was to accelerate the commercialization of medical device technologies through internal development activities and collaboration with major institutions and OEM partners. In 1998, BIOMEC developed a proven methodology to obtain and execute Small Business Innovation Research (SBIR) government grants that supported many of its product development programs. Prior to the transaction with Greatbatch, BIOMEC had been awarded 51 of these SBIR grants with a value of $25 million, an average of almost one per month, since receiving its first grant in March 1999. This volume of grants allowed BIOMEC to develop extensive engineering capabilities in several high-growth medical technology areas, including non-invasive diagnostic devices like the Pneumothorax Detector.